The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study
Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriopha...
Saved in:
Published in | Gut microbes Vol. 10; no. 6; pp. 676 - 687 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
02.11.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1949-0976 1949-0984 1949-0984 |
DOI | 10.1080/19490976.2019.1586037 |
Cover
Abstract | Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.
Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.
In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT. |
---|---|
AbstractList | Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT. Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT. Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT. : Fecal microbial transplantation (FMT) is used in the treatment of relapsing infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. : Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of and . A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. : In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT. |
Author | Hotte, Naomi Millan, Braden Laffin, Michael R. Madsen, Karen L. Park, Heekuk Jovel, Juan Hyun, Jae E. Kao, Dina |
Author_xml | – sequence: 1 givenname: Heekuk orcidid: 0000-0001-5815-9717 surname: Park fullname: Park, Heekuk organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 2 givenname: Michael R. surname: Laffin fullname: Laffin, Michael R. organization: University of Alberta – sequence: 3 givenname: Juan surname: Jovel fullname: Jovel, Juan organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 4 givenname: Braden surname: Millan fullname: Millan, Braden organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 5 givenname: Jae E. surname: Hyun fullname: Hyun, Jae E. organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 6 givenname: Naomi surname: Hotte fullname: Hotte, Naomi organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 7 givenname: Dina orcidid: 0000-0002-6096-0586 surname: Kao fullname: Kao, Dina organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research – sequence: 8 givenname: Karen L. orcidid: 0000-0002-8636-0714 surname: Madsen fullname: Madsen, Karen L. email: Karen.madsen@ualberta.ca organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30866714$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkstu1DAUhiNUREvpI4C8ZDODnYvjgIRAI25SJTZlbZ340hg5drCdjuaheEecZlouC8AbWz7__x_bnx8XJ847VRRPCd4SzPAL0tUd7lq6LTHptqRhFFftg-Js2d_gjtUn9-uWnhYXMX7FedR1i2n1qDitMKO0JfVZ8f1qUCjOQqgYkddIKwEWjUYE35u8SgFcnCy4BMl4h4xDO-tjCkaaeUTSaG2EsSoXsvVWInwIykJSEe1NGlAPIqlg_DTAtUK3JXOjEPSzk-DEYkUpn0J658NLBFmSgo_TEpd1wg8-JBTTLA9PiocabFQXx_m8-PL-3dXu4-by84dPu7eXG1FTljayBoASN50uNW1Z2euWEQoU675r61Y3LS5ZL7O4lIQwxWRV1Q3IvillpytRnRd0zZ3dBIc9WMunYEYIB04wXxDwOwR8QcCPCLLx9Wqc5n5UUiiXH_Cn2YPhv1ecGfi1v-GUZR6szAHPjwHBf5tVTHw0USibCSg_R16SjlSUYLJIn_3a677JHdwsaFZBhhljUPq_L_HqD58wK_58ZGP_6X6zuvOP8GGEvQ9W8gQH64POv0mYyKu_R_wA-67j7g |
CitedBy_id | crossref_primary_10_1016_j_eclinm_2020_100642 crossref_primary_10_3389_fcimb_2021_755650 crossref_primary_10_3390_nu13031018 crossref_primary_10_1038_s41575_021_00441_5 crossref_primary_10_1038_s41575_022_00610_0 crossref_primary_10_1128_aem_02265_24 crossref_primary_10_1016_j_copbio_2020_09_016 crossref_primary_10_3390_microorganisms11051181 crossref_primary_10_1016_j_csbj_2022_01_009 crossref_primary_10_5812_jjm_129130 crossref_primary_10_1051_medsci_2022169 crossref_primary_10_1016_j_cmi_2023_01_018 crossref_primary_10_1016_j_jad_2024_03_088 crossref_primary_10_2147_JIR_S338212 crossref_primary_10_1016_j_micres_2021_126942 crossref_primary_10_3389_fcimb_2021_822562 crossref_primary_10_1093_femsec_fiad068 crossref_primary_10_1136_gutjnl_2019_320005 crossref_primary_10_3389_fmicb_2025_1556827 crossref_primary_10_1016_j_cmi_2022_11_012 crossref_primary_10_1016_j_mib_2020_05_008 crossref_primary_10_1016_S2468_1253_21_00303_4 crossref_primary_10_1080_1061186X_2023_2299724 crossref_primary_10_3389_fcimb_2021_643214 crossref_primary_10_1111_apt_15557 crossref_primary_10_1093_bioinformatics_btad236 crossref_primary_10_1016_j_lfs_2022_120719 crossref_primary_10_1016_j_coviro_2019_06_003 crossref_primary_10_1080_19490976_2020_1810531 crossref_primary_10_1007_s10620_020_06676_7 crossref_primary_10_1038_s41390_019_0491_8 crossref_primary_10_48022_mbl_2212_12002 crossref_primary_10_1007_s12016_023_08958_0 crossref_primary_10_1038_s41575_020_0350_4 crossref_primary_10_1002_jpen_2333 crossref_primary_10_1053_j_gastro_2020_09_057 |
Cites_doi | 10.1101/gr.122705.111 10.1086/315239 10.1053/j.gastro.2014.07.020 10.1126/science.1177486 10.1046/j.1365-2958.1998.00947.x 10.1128/mBio.00260-11 10.1101/gr.138297.112 10.1053/j.gastro.2016.11.010 10.1128/mSystems.00127-16 10.1128/JB.188.7.2726-2729.2006 10.7326/M14-2693 10.1038/nature12212 10.1007/s11908-017-0586-5 10.4161/gmic.22371 10.1136/gutjnl-2017-313952 10.1073/pnas.1601060113 10.1126/science.1165771 10.1016/S1473-3099(05)70215-2 10.1038/nrgastro.2016.98 10.1016/j.vetmic.2007.11.032 10.1016/0027-5107(92)90106-C 10.1016/j.cgh.2011.08.014 10.1002/cpt.747 10.1086/525047 10.1186/gb-2014-15-3-r46 10.1093/bioinformatics/btu616 10.1016/j.coviro.2011.06.009 10.1016/j.bbrc.2015.12.083 10.1128/mBio.00322-16 10.1001/jama.2017.17077 10.1080/19490976.2016.1278105 10.1186/2049-2618-2-13 10.1126/science.1159689 10.1016/j.cell.2012.10.052 10.1016/j.tim.2014.02.010 10.1097/MCG.0000000000000374 10.1371/journal.pone.0000799 10.3389/fmicb.2018.00749 10.3748/wjg.v21.i17.5359 10.1038/msb.2013.22 10.1038/nature09199 10.1038/ismej.2014.30 10.1073/pnas.1300833110 10.1097/MCG.0000000000000410 10.1097/MCG.0b013e3181c87e02 |
ContentType | Journal Article |
Copyright | 2019 Taylor & Francis Group, LLC 2019 2019 Taylor & Francis Group, LLC 2019 Taylor & Francis |
Copyright_xml | – notice: 2019 Taylor & Francis Group, LLC 2019 – notice: 2019 Taylor & Francis Group, LLC 2019 Taylor & Francis |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
DOI | 10.1080/19490976.2019.1586037 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | H. PARK ET AL |
EISSN | 1949-0984 |
EndPage | 687 |
ExternalDocumentID | 10.1080/19490976.2019.1586037 PMC6867182 30866714 10_1080_19490976_2019_1586037 1586037 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: CIHR – fundername: ; – fundername: ; ; |
GroupedDBID | --- 00X 0YH 30N 4.4 53G ABPEM ACGFS ACTIO ADBBV ADCVX AEISY AGYJP AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS AQRUH BABNJ BAWUL BLEHA CCCUG DGEBU DIK DKSSO EBS EMOBN F5P GROUPED_DOAJ H13 HYE IPNFZ KYCEM LJTGL M4Z MM. O9- OK1 RIG RPM SNACF SV3 TDBHL TFL TFT TFW TR2 TTHFI AAYXX AIYEW CITATION ABCCY C1A CGR CUY CVF ECM EIF EJD NPM OVD TEORI 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c468t-d4aaa2059f2f6782bf7816a60fb9747f57028bdc462d118e8d3345adb52d9f3c3 |
ISSN | 1949-0976 1949-0984 |
IngestDate | Tue Aug 19 20:46:36 EDT 2025 Tue Sep 30 16:49:34 EDT 2025 Fri Jul 11 13:05:09 EDT 2025 Thu Apr 03 07:05:35 EDT 2025 Thu Apr 24 22:55:24 EDT 2025 Tue Jul 01 03:30:36 EDT 2025 Wed Dec 25 09:08:12 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | FMT Clostridium difficile infection intestinal microbiome bacteriophages |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c468t-d4aaa2059f2f6782bf7816a60fb9747f57028bdc462d118e8d3345adb52d9f3c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Braden Millan, Cumming School of Medicine, University of Calgary, Calgary, Alberta |
ORCID | 0000-0002-6096-0586 0000-0002-8636-0714 0000-0001-5815-9717 |
OpenAccessLink | https://www.tandfonline.com/doi/pdf/10.1080/19490976.2019.1586037?needAccess=true |
PMID | 30866714 |
PQID | 2191361012 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | crossref_primary_10_1080_19490976_2019_1586037 pubmed_primary_30866714 proquest_miscellaneous_2191361012 unpaywall_primary_10_1080_19490976_2019_1586037 crossref_citationtrail_10_1080_19490976_2019_1586037 informaworld_taylorfrancis_310_1080_19490976_2019_1586037 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6867182 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-11-02 |
PublicationDateYYYYMMDD | 2019-11-02 |
PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Gut microbes |
PublicationTitleAlternate | Gut Microbes |
PublicationYear | 2019 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | cit0011 cit0033 cit0012 cit0034 cit0031 cit0010 cit0032 cit0030 cit0019 cit0017 cit0039 cit0018 cit0015 cit0037 cit0016 cit0038 cit0013 cit0035 cit0014 cit0036 cit0022 cit0044 cit0001 cit0023 cit0045 cit0020 cit0042 cit0021 cit0043 cit0040 cit0041 cit0008 cit0009 cit0006 cit0028 cit0007 cit0029 cit0004 cit0026 cit0005 cit0027 cit0002 cit0024 cit0003 cit0025 |
References_xml | – ident: cit0018 doi: 10.1101/gr.122705.111 – ident: cit0022 doi: 10.1086/315239 – ident: cit0030 doi: 10.1053/j.gastro.2014.07.020 – ident: cit0037 doi: 10.1126/science.1177486 – ident: cit0020 doi: 10.1046/j.1365-2958.1998.00947.x – ident: cit0033 doi: 10.1128/mBio.00260-11 – ident: cit0017 doi: 10.1101/gr.138297.112 – ident: cit0014 doi: 10.1053/j.gastro.2016.11.010 – ident: cit0044 doi: 10.1128/mSystems.00127-16 – ident: cit0021 doi: 10.1128/JB.188.7.2726-2729.2006 – ident: cit0026 doi: 10.7326/M14-2693 – ident: cit0036 doi: 10.1038/nature12212 – ident: cit0006 doi: 10.1007/s11908-017-0586-5 – ident: cit0010 doi: 10.4161/gmic.22371 – ident: cit0015 doi: 10.1136/gutjnl-2017-313952 – ident: cit0013 doi: 10.1073/pnas.1601060113 – ident: cit0041 doi: 10.1126/science.1165771 – ident: cit0001 doi: 10.1016/S1473-3099(05)70215-2 – ident: cit0029 doi: 10.1038/nrgastro.2016.98 – ident: cit0023 doi: 10.1016/j.vetmic.2007.11.032 – ident: cit0035 doi: 10.1016/0027-5107(92)90106-C – ident: cit0002 doi: 10.1016/j.cgh.2011.08.014 – ident: cit0007 doi: 10.1002/cpt.747 – ident: cit0031 doi: 10.1086/525047 – ident: cit0043 doi: 10.1186/gb-2014-15-3-r46 – ident: cit0045 doi: 10.1093/bioinformatics/btu616 – ident: cit0039 doi: 10.1016/j.coviro.2011.06.009 – ident: cit0024 doi: 10.1016/j.bbrc.2015.12.083 – ident: cit0011 doi: 10.1128/mBio.00322-16 – ident: cit0042 doi: 10.1001/jama.2017.17077 – ident: cit0008 doi: 10.1080/19490976.2016.1278105 – ident: cit0028 doi: 10.1186/2049-2618-2-13 – ident: cit0040 doi: 10.1126/science.1159689 – ident: cit0032 doi: 10.1016/j.cell.2012.10.052 – ident: cit0009 doi: 10.1016/j.tim.2014.02.010 – ident: cit0005 doi: 10.1097/MCG.0000000000000374 – ident: cit0034 doi: 10.1371/journal.pone.0000799 – ident: cit0038 doi: 10.3389/fmicb.2018.00749 – ident: cit0003 doi: 10.3748/wjg.v21.i17.5359 – ident: cit0025 doi: 10.1038/msb.2013.22 – ident: cit0012 doi: 10.1038/nature09199 – ident: cit0019 doi: 10.1038/ismej.2014.30 – ident: cit0016 doi: 10.1073/pnas.1300833110 – ident: cit0004 doi: 10.1097/MCG.0000000000000410 – ident: cit0027 doi: 10.1097/MCG.0b013e3181c87e02 |
SSID | ssj0000447063 |
Score | 2.3943105 |
Snippet | Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but... : Fecal microbial transplantation (FMT) is used in the treatment of relapsing infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms... Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 676 |
SubjectTerms | Adult Aged Aged, 80 and over Bacteria - classification Bacteria - genetics Bacteria - isolation & purification bacteriophages Bacteriophages - classification Bacteriophages - genetics Clostridium difficile - physiology Clostridium difficile infection Clostridium Infections - microbiology Clostridium Infections - therapy Clostridium Infections - virology Cohort Studies Fecal Microbiota Transplantation Feces - microbiology Feces - virology Female FMT Gastrointestinal Microbiome - genetics Humans intestinal microbiome Male Middle Aged Recurrence Research Paper/Report Retrospective Studies Tissue Donors Treatment Outcome |
Title | The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study |
URI | https://www.tandfonline.com/doi/abs/10.1080/19490976.2019.1586037 https://www.ncbi.nlm.nih.gov/pubmed/30866714 https://www.proquest.com/docview/2191361012 https://pubmed.ncbi.nlm.nih.gov/PMC6867182 https://www.tandfonline.com/doi/pdf/10.1080/19490976.2019.1586037?needAccess=true |
UnpaywallVersion | publishedVersion |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1949-0984 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0000447063 issn: 1949-0976 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1949-0984 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000447063 issn: 1949-0976 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAWR databaseName: Taylor & Francis Science and Technology Library-DRAA customDbUrl: eissn: 1949-0984 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000447063 issn: 1949-0976 databaseCode: 30N dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.tandfonline.com/page/title-lists providerName: Taylor & Francis |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db5swFLWiTtv6Mu172Zc8aW8RKQFiYG9TtS2qtqqaUqlvyICtRk0gSqFT95_2z_Yjdq9tDLSR2vUFJQSD4R7b95Jz7iXkYzRNQxGmriPdUDqBkLmTskg4WQbDT7qCe1wRZA_Z7Dg4OJmeDAZ_O6ylukrH2e-tupK7WBX2gV1RJfsflrUnhR3wGewLW7AwbG9t4_NalTxEp08KfOCrhcqtpEjkmLh8yQvDKESB37LEQh35ol6p2iiLDGYFy8hCSvpGqVuEUb2lOplzuT5Fbo8WvlyIEU9RQIJzgqFJ5mVRbrRweiOqTdkIOEdYgHdTdbLYGkf4W12ZnrYkxiPD254JcVZbBdF3Dt3sUvxHP8ct7-dCswwO6hblKG_Ur3WRKGCkbubFxiRWCr82DJ5fqzHSmabjAIleoUmi3d2nC87Zud3tYLg7UbOmrf6mF_1ry4nmX-KZ8WJIBIzHk2nEXL93PDze9UphzIcIkYVaFnslj_fRj32GyQQjcBjueSFjWG_Ddw_tG0E3CEJd-s_eXiM5i9y9rZ3YJQ-aK_b8ql7W3W2x03UK8MO6WPPLX3y57PhX88fkkQmM6GeN8idkIIqn5L4ulXr5jPwBrFODdVpKqrBOLdbpFazTRUE7WKcW69RinbZYp4h12sM6bbBOLdbxnIB1qrD-iXLaQzrVSKcK6c_J8dcv8_2ZY0qNOFnAosrJA865B6GG9CS4b14qw2jCOHNligG3nIbgh6c5HOzlEJKLKPf9YMrzdOrlsfQz_wXZKcpCvCI049zPcOHMJZjMy1OIIWLuRkEsGQb8QxI0hkoyk4cfy8Esk4lJ19uYOkFTJ8bUQzK2zdY6Ec1NDeIuCpJKjSeph1Li39D2QwOZBJYb_A-RF6KszxNwcCY-w6SAQ_JSQ8h2p4HikIQ9cNkDMJV9_5dicapS2puRMSR7Foa3u8vXd77WG7LbzjpvyU61qcU7CDCq9L0al_8AcHEn6Q |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagCJUX7mM5jcRrtjmdhDdUUS1Q9qmV-hb5VKOmzmqbgMp_4j8yYyfRLoeK1LdI8VhxPJnDmfk-Qt4Vmch1LsLAhLkJUm1UIFihAynh8zOh5jF3BbJLtjhOP59kJxu9MFhWiTm08UARzlbjx42H0WNJ3B4k3mUIfhQrs8p5lBUsTPKb5FaGSCPYxhEup3OWME1zT6iGUgGKjY08_5ppy0VtAZj-LQz9s5pyt7crfvmdN82Gqzq4R-S4SF-hcjbvOzGXP37Df7zeW7hP7g6RLP3gVe8BuaHtQ3Lbc1tePiI_QQHpRe_4GGlrqNGgDfS8dsBPcNU5VPWG-9YnS2tL95sWWURU3Z9TJG6pJZgsOpaLWSqRSaTB4Jji8TEVHmm6XZ2CUaS-K-ebplxgdwsoM84J8S1VrW3X7ymHId26HXtLKXIDrzvqAHYfk-ODj0f7i2DghghkyoouUCnnPIbY0MQG_G0sTF5EjLPQCMyQTJZD4CQUDI4V5FC6UEmSZlyJLFalSWTyhOzY1upnhErOE4mWThl4o7ESEPSVPCzS0jDM0GYkHdWhkgNwOvJ3NFU04KuOO1HhTlTDTszIfBJbeeSQqwTKTV2rOndkYzy_SpVcIft2VMwK7AP-9OFWt_1FBR4pShiiuM3IU6-o0-MkkM-yPEpnJN9S4WkAYo9v37H1qcMgZ4iLWMCce5Oy_98qn19jlW_I7uLo62F1-Gn55QW5g7dcW2j8kux0616_gviwE6-dAfgF7r9aBA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagiOOFs8ByGonXbHM4TsIbKqzKoRUPVOItsmNbjUid1W7Sqvwn_iMzdhJ1OVSkvq0Uj7WOx3M4M99HyOs8lZnOZBiYMDMB00YFkuc6qCo4fibUIhauQHbJDw7Zx2_pWE24GcoqMYc2HijC2Wo83Ctlxoq4Pci7ixDcKBZmFfMozXmYZFfJNY59ptjFES6na5aQsczzqaFUgGJjH8-_ZtryUFv4pX-LQv8sprzZ25U4OxVNc85TLe4QOa7RF6h8n_ednFc_foN_vNRLuEtuD3EsfesV7x65ou19ct0zW549ID9B_eimd2yMtDXUaNAFelw72Cf41TlM9Ub4xidLa0v3mxY5RFTdH1OkbakrMFh0LBaztEIekQZDY4qXx1R6nOl2dQQmkfqenBNNhcTeFlBlnBOiW6pa267fUAFDunU7dpZSZAZed9TB6-6Sw8X7r_sHwcAMEVSM512gmBAihsjQxAa8bSxNlkdc8NBIzI9MmkHYJBUMjhVkUDpXScJSoWQaq8IkVfKQ7NjW6seEVkIkFdo5ZeCNxkpCyFeIMGeF4ZifzQgbtaGsBth0ZO9oymhAVx13osSdKIedmJH5JLbyuCEXCRTnVa3s3IWN8ewqZXKB7KtRL0uwDvjJR1jd9psS_FGUcMRwm5FHXk-nv5NANsuziM1ItqXB0wBEHt9-Yusjh0DOERUxhzn3Jl3_v1U-ucQqX5IbX94tys8flp-eklv4xPWExs_ITrfu9XMIDjv5wh3_X4j8WLE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+success+of+fecal+microbial+transplantation+in+Clostridium+difficile+infection+correlates+with+bacteriophage+relative+abundance+in+the+donor%3A+a+retrospective+cohort+study&rft.jtitle=Gut+microbes&rft.au=Park%2C+Heekuk&rft.au=Laffin%2C+Michael+R.&rft.au=Jovel%2C+Juan&rft.au=Millan%2C+Braden&rft.date=2019-11-02&rft.pub=Taylor+%26+Francis&rft.issn=1949-0976&rft.eissn=1949-0984&rft.volume=10&rft.issue=6&rft.spage=676&rft.epage=687&rft_id=info:doi/10.1080%2F19490976.2019.1586037&rft_id=info%3Apmid%2F30866714&rft.externalDocID=PMC6867182 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-0976&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-0976&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-0976&client=summon |